Skip to content
Axcess News – Lifestyle
Author:
Radiopharm Theranostics
Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
March 24, 2026
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
March 5, 2026
←
Previous Page
1
2